These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 191115)

  • 1. Genetic influence in murine viral leukemogenesis.
    Meredith RF; Okunewick JP
    Biomedicine; 1976 Dec; 24(6):374-80. PubMed ID: 191115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of H-2 complex on susceptibility to infection by murine leukemia virus.
    Tucker HSt ; Weens J; Tsichlis P; Schwartz RS; Khiroya R; Donnelly J
    J Immunol; 1977 Apr; 118(4):1239-43. PubMed ID: 191531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
    Green WR
    J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of H-2 class I gene expression in virally transformed and infected cells.
    Brown GD; Choi Y; Pampeno C; Meruelo D
    Crit Rev Immunol; 1988; 8(3):175-215. PubMed ID: 3280242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
    Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
    J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and phenotypic heterogeneity of Moloney virus-induced leukemias: a multigenic control.
    Debre P; Gisselbrecht S; Boyer B; Levy JP
    Blood Cells; 1981; 7(2):301-11. PubMed ID: 6975141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of G mice to murine leukemia virus infection: apparent disparity in in vivo and in vitro resistances.
    Yoshikura H; Odaka T
    J Natl Cancer Inst; 1978 Aug; 61(2):461-3. PubMed ID: 277731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
    Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
    Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility and resistance to viral leukemogenesis in the mouse. IV. Mechanisms of host resistance to leukemia expression.
    Tennant JR
    J Natl Cancer Inst; 1972 Nov; 49(5):1257-67. PubMed ID: 4346533
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of antinuclear antibodies in mice infected with Rauscher leukemia virus.
    Varet B; Cannat A; Gisselbrecht S
    Cancer Res; 1977 Apr; 37(4):1115-8. PubMed ID: 300277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
    Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome.
    Makino M; Morse HC; Fredrickson TN; Hartley JW
    J Immunol; 1990 Jun; 144(11):4347-55. PubMed ID: 2160500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry.
    Yokomori K; Asanaka M; Stohlman SA; Lai MM
    Virology; 1993 Sep; 196(1):45-56. PubMed ID: 8395126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
    Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
    J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.